Comparative evaluation of Immunogenicity of inactivated vaccines produced from Cell culture and Embryonated Eggs’culture antigens against Infectiousbursal disease virus
محل انتشار: هفتمین کنگره بین المللی دامپزشکی طیور
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 368
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
IVPC07_019
تاریخ نمایه سازی: 22 اردیبهشت 1400
چکیده مقاله:
Infectious bursal disease (IBD) is an extremely contagious and immunosuppressive disease of poultry. Forprevention and reduction of economic losses, one of the best intervention approaches for immunosuppressive diseases is increasing immune responses by use of more effective vaccines. The purpose of this study was to evaluate immunogenicity cell culture in chick embryo fibroblast (CEF) cells and embryonated eggs’ culture based vaccines against infectious bursal disease. Two inactivated oil vaccines according to cell culture (group ۱) and SPF egg embryonic culture (group ۲) vaccine are produced. Immunogenicity of vaccines was examined in SPF ۲۱ day’s old chicken by ELISA assay. Results of study revealed that, the antibody titers in group ۱ were significantly higher than group ۲ at the first month after vaccination. It seems that the vaccines derived from cell culture are more capable of initiating antibody titers and the use of cell culture vaccines could produce stronger immunity in the first weeks of bird’s life when they are more sensitive to IBD.
کلیدواژه ها:
نویسندگان
Ali Ameghi Roodsary
Razi Vaccine and Serum Research Institute Karaj
Seyyed Mehdi Mousaviyan
Department of Research and Development, Razi Vaccine and Serum Research Institute Northwest Branch
Nasser Razmaraii
Department of Research and Development, Razi Vaccine and Serum Research Institute Northwest Branch
Davood Delkhoshi
Department of Research and Development, Razi Vaccine and Serum Research Institute Northwest Branch
Mohammad Ali Jafargolipour
Department of Research and Development, Razi Vaccine and Serum Research Institute Northwest Branch